PODD vs. DXCM

Last updated Jun 3, 2026

PODD (Insulet Corporation) and DXCM (DexCom, Inc.) are both stocks. Both are in the Healthcare sector — PODD in Medical Devices, DXCM in Diagnostics & Research. Over the past 10 years, PODD returned 16.27%/yr vs 15.84%/yr for DXCM. At a 0.47 correlation, their price movements are largely independent.

Performance

PODD vs. DXCM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Insulet Corporation (PODD) and DexCom, Inc. (DXCM). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, PODD achieves a -49.89% return, which is significantly lower than DXCM's 10.67% return. Both investments have delivered pretty close results over the past 10 years, with PODD having a 16.27% annualized return and DXCM not far behind at 15.84%.

PODD

• 1D: -3.85%
• 1M: -18.63%
• YTD: -49.89%
• 6M: -53.91%
• 1Y: -56.18%
• 3Y*: -20.27%
• 5Y*: -11.60%
• 10Y*: 16.27%

DXCM

• 1D: -1.90%
• 1M: 19.72%
• YTD: 10.67%
• 6M: 13.96%
• 1Y: -14.10%
• 3Y*: -15.69%
• 5Y*: -4.85%
• 10Y*: 15.84%

*Multi-year figures are annualized to reflect compound growth (CAGR)

PODD vs. DXCM - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
PODD Insulet Corporation	-49.89%	8.88%	20.32%	-26.30%	10.64%	4.08%	49.32%	115.83%	14.96%	83.12%
DXCM DexCom, Inc.	10.67%	-14.66%	-37.33%	9.58%	-15.64%	45.23%	69.02%	82.59%	108.75%	-3.87%

Correlation

The correlation between PODD and DXCM is 0.46, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.46
Correlation (3Y) Calculated over the trailing 3-year period	0.52
Correlation (5Y) Calculated over the trailing 5-year period	0.56
Correlation (10Y) Calculated over the trailing 10-year period	0.55
Correlation (All Time) Calculated using the full available price history since May 16, 2007	0.47

The correlation between PODD and DXCM shifts across timeframes, from 0.46 (1 year) to 0.56 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap PODD : $10.00B DXCM : $28.91B
EPS PODD : $4.29 DXCM : $2.31
PE Ratio PODD : 33.18 DXCM : 31.74
PEG Ratio PODD : 0.03 DXCM : 0.75
PS Ratio PODD : 3.46 DXCM : 6.13
PB Ratio PODD : 7.68 DXCM : 9.78
Total Revenue (TTM) PODD : $2.90B DXCM : $4.82B
Gross Profit (TTM) PODD : $2.06B DXCM : $2.96B
EBITDA (TTM) PODD : $529.70M DXCM : $1.37B

Return for Risk

PODD vs. DXCM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PODD

PODD Risk / Return Rank: 1
PODD Sharpe Ratio Rank: 0
PODD Sortino Ratio Rank: 1
PODD Omega Ratio Rank: 1
PODD Calmar Ratio Rank: 4
PODD Martin Ratio Rank: 1

DXCM

DXCM Risk / Return Rank: 26
DXCM Sharpe Ratio Rank: 25
DXCM Sortino Ratio Rank: 24
DXCM Omega Ratio Rank: 24
DXCM Calmar Ratio Rank: 28
DXCM Martin Ratio Rank: 28

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PODD vs. DXCM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Insulet Corporation (PODD) and DexCom, Inc. (DXCM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	PODD	DXCM	Difference
Sharpe ratio Return per unit of total volatility	-1.52	-0.35	-1.17
Sortino ratio Return per unit of downside risk	-2.51	-0.23	-2.27
Omega ratio Gain probability vs. loss probability	0.69	0.97	-0.28
Calmar ratio Return relative to maximum drawdown	-0.94	-0.37	-0.57
Martin ratio Return relative to average drawdown	-2.11	-0.64	-1.47
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

PODD vs. DXCM - Sharpe Ratio Comparison

The current PODD Sharpe Ratio is -1.52, which is lower than the DXCM Sharpe Ratio of -0.35. The chart below compares the historical Sharpe Ratios of PODD and DXCM, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	PODD	DXCM	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-1.52	-0.35	-1.17
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.27	-0.10	-0.17
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.38	0.33	+0.06
Sharpe Ratio (All Time) Calculated using the full available price history	0.24	0.30	-0.06

Drawdowns

PODD vs. DXCM - Drawdown Comparison

The maximum PODD drawdown since its inception was -90.28%, roughly equal to the maximum DXCM drawdown of -94.61%. Use the drawdown chart below to compare losses from any high point for PODD and DXCM.

Drawdown Indicators

	PODD	DXCM	Difference
Max Drawdown Largest peak-to-trough decline	-90.28%	-94.61%	+4.33%
Max Drawdown (1Y) Largest decline over 1 year	-59.63%	-38.75%	-20.88%
Max Drawdown (3Y) Largest decline over 3 years	-59.63%	-60.95%	+1.32%
Max Drawdown (5Y) Largest decline over 5 years	-61.31%	-66.32%	+5.01%
Max Drawdown (10Y) Largest decline over 10 years	-61.31%	-66.32%	+5.01%
Current Drawdown Current decline from peak	-59.63%	-54.89%	-4.74%
Average Drawdown Average peak-to-trough decline	-24.87%	-35.99%	+11.12%
Ulcer Index Depth and duration of drawdowns from previous peaks	26.68%	22.60%	+4.08%

Volatility

PODD vs. DXCM - Volatility Comparison

Insulet Corporation (PODD) has a higher volatility of 16.58% compared to DexCom, Inc. (DXCM) at 13.45%. This indicates that PODD's price experiences larger fluctuations and is considered to be riskier than DXCM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	PODD	DXCM	Difference
Volatility (1M) Calculated over the trailing 1-month period	16.58%	13.45%	+3.13%
Volatility (6M) Calculated over the trailing 6-month period	29.62%	24.59%	+5.03%
Volatility (1Y) Calculated over the trailing 1-year period	37.08%	40.25%	-3.17%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	42.61%	46.92%	-4.31%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	42.47%	48.44%	-5.97%

Dividends

PODD vs. DXCM - Dividend Comparison

Neither PODD nor DXCM has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

PODD vs. DXCM - Profitability Comparison

The chart below illustrates the profitability comparison between Insulet Corporation and DexCom, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

PODD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Insulet Corporation reported a gross profit of 529.10M and revenue of 761.70M. Therefore, the gross margin over that period was 69.5%.

DXCM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, DexCom, Inc. reported a gross profit of 750.30M and revenue of 1.19B. Therefore, the gross margin over that period was 63.0%.

PODD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Insulet Corporation reported an operating income of 122.10M and revenue of 761.70M, resulting in an operating margin of 16.0%.

DXCM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, DexCom, Inc. reported an operating income of 255.30M and revenue of 1.19B, resulting in an operating margin of 21.4%.

PODD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Insulet Corporation reported a net income of 91.10M and revenue of 761.70M, resulting in a net margin of 12.0%.

DXCM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, DexCom, Inc. reported a net income of 199.50M and revenue of 1.19B, resulting in a net margin of 16.7%.

Frequently Asked Questions

Can I hold both PODD and DXCM in my portfolio?

PODD and DXCM have a correlation of 0.46, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, PODD or DXCM?

PODD has higher volatility (16.58%) compared to DXCM (13.45%). In terms of maximum drawdown, PODD dropped -90.28% vs DXCM's -94.61%.

Which has better risk-adjusted returns?

DXCM currently has the higher Sharpe Ratio (-0.35 vs -1.52), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.